Insurer And Patient Drug Costs Soared For Top-Sellers Over 6-Year Study
Executive Summary
Median out-of-pocket and insurance costs for 49 high-volume brand-name drugs jumped 79% from 2012 to 2017 in a new analysis of 35m individual insurance claims published in JAMA Network. Competition did not correlate to lower costs.